A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old thai children, concomitantly with japanese encephalitis vaccine

After concomitant administration of purified chick embryo cell rabies vaccine and Japanese encephalitis vaccine to toddlers, adequate rabies and Japanese encephalitis virus neutralizing antibodies concentrations were demonstrated by day 49, 7 days after a booster at 1 year, and in the majorly at 3 y...

Full description

Saved in:
Bibliographic Details
Main Authors: Krisana Pengsaa, Kriengsak Limkittikul, Arunee Sabchareon, Churdchoo Ariyasriwatana, Pornthep Chanthavanich, Phanosri Attanath, Claudius Malerczyk
Other Authors: Mahidol University
Format: Article
Published: 2018
Subjects:
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/28271
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University
id th-mahidol.28271
record_format dspace
spelling th-mahidol.282712018-09-13T14:08:21Z A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old thai children, concomitantly with japanese encephalitis vaccine Krisana Pengsaa Kriengsak Limkittikul Arunee Sabchareon Churdchoo Ariyasriwatana Pornthep Chanthavanich Phanosri Attanath Claudius Malerczyk Mahidol University Queen Sirikit National Institute of Child Health Novartis Vaccines and Diagnostics Medicine After concomitant administration of purified chick embryo cell rabies vaccine and Japanese encephalitis vaccine to toddlers, adequate rabies and Japanese encephalitis virus neutralizing antibodies concentrations were demonstrated by day 49, 7 days after a booster at 1 year, and in the majorly at 3 years postvaccination. The inclusion of rabies vaccine in the expanded program on immunization should be considered in rabies endemic countries. Copyright © 2009 by Lippincott Williams & Wilkins. 2018-09-13T07:08:21Z 2018-09-13T07:08:21Z 2009-01-01 Article Pediatric Infectious Disease Journal. Vol.28, No.4 (2009), 335-337 10.1097/INF.0b013e3181906351 15320987 08913668 2-s2.0-65649111203 https://repository.li.mahidol.ac.th/handle/123456789/28271 Mahidol University SCOPUS https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=65649111203&origin=inward
institution Mahidol University
building Mahidol University Library
continent Asia
country Thailand
Thailand
content_provider Mahidol University Library
collection Mahidol University Institutional Repository
topic Medicine
spellingShingle Medicine
Krisana Pengsaa
Kriengsak Limkittikul
Arunee Sabchareon
Churdchoo Ariyasriwatana
Pornthep Chanthavanich
Phanosri Attanath
Claudius Malerczyk
A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old thai children, concomitantly with japanese encephalitis vaccine
description After concomitant administration of purified chick embryo cell rabies vaccine and Japanese encephalitis vaccine to toddlers, adequate rabies and Japanese encephalitis virus neutralizing antibodies concentrations were demonstrated by day 49, 7 days after a booster at 1 year, and in the majorly at 3 years postvaccination. The inclusion of rabies vaccine in the expanded program on immunization should be considered in rabies endemic countries. Copyright © 2009 by Lippincott Williams & Wilkins.
author2 Mahidol University
author_facet Mahidol University
Krisana Pengsaa
Kriengsak Limkittikul
Arunee Sabchareon
Churdchoo Ariyasriwatana
Pornthep Chanthavanich
Phanosri Attanath
Claudius Malerczyk
format Article
author Krisana Pengsaa
Kriengsak Limkittikul
Arunee Sabchareon
Churdchoo Ariyasriwatana
Pornthep Chanthavanich
Phanosri Attanath
Claudius Malerczyk
author_sort Krisana Pengsaa
title A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old thai children, concomitantly with japanese encephalitis vaccine
title_short A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old thai children, concomitantly with japanese encephalitis vaccine
title_full A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old thai children, concomitantly with japanese encephalitis vaccine
title_fullStr A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old thai children, concomitantly with japanese encephalitis vaccine
title_full_unstemmed A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old thai children, concomitantly with japanese encephalitis vaccine
title_sort three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old thai children, concomitantly with japanese encephalitis vaccine
publishDate 2018
url https://repository.li.mahidol.ac.th/handle/123456789/28271
_version_ 1763487528147484672